Your browser doesn't support javascript.
loading
Prostate-specific antigen doubling time following radium-223 treatment as a predictor of the clinical course in patients with metastatic castration-resistant prostate cancer.
Kawaguchi, Gen; Akazawa, Kohei; Ikeda, Taro; Ikeda, Yohei; Hara, Noboru; Nishiyama, Tsutomu.
Affiliation
  • Kawaguchi G; Department of Radiotherapy, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Japan.
  • Akazawa K; Department of Medical Informatics, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Ikeda T; Department of Urology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Japan.
  • Ikeda Y; Department of Diagnostic Radiology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Niigata, Japan.
  • Hara N; Department of Urology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Japan.
  • Nishiyama T; Department of Urology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Japan.
SAGE Open Med ; 11: 20503121231168493, 2023.
Article in En | MEDLINE | ID: mdl-37113623
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: SAGE Open Med Year: 2023 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: SAGE Open Med Year: 2023 Document type: Article Affiliation country: Japón